Overcoming 103 Rejections for Biotech and Chemical Patents: Leveraging Recent Decisions and USPTO Guidance

As part of Strafford Publications’ webinar series, Finnegan partners Tom Irving, Adriana Burgy, Jeffrey Jacobstein, and Amanda Murphy will provide guidance to patent counsel for overcoming Section 103 rejections for biotech and chemical patents and discuss the recent and more frequent appearance of inherency arguments in an obviousness context, as well as several Federal Circuit decisions reminding the PTAB that conclusions of obviousness must be sufficiently supported and cannot be conclusory and merely stated to be based on "common sense.”